GlassScriptPhysician profile
Miranda L Tsoumas
NPI 1164839684
$821.38
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $199 · 2022: $289 · 2023: $249 · 2024: $84.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $333.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $217.99 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $95.74 | 2022-2023 | Spravato |
| Biohaven Pharmaceutical Holding Company LTD. | $65.07 | 2022 | |
| Glaxosmithkline, LLC. | $61.65 | 2021-2023 | Bexsero, Shingrix |
| Novo Nordisk INC | $57.73 | 2022-2024 | Rybelsus, Ozempic |
| Abbott Laboratories | $46.61 | 2022-2023 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $42.52 | 2021-2023 | Vaxneuvance, Proquad, M-M-R II |
| Astellas Pharma US INC | $39.77 | 2023-2024 | Veozah, Myrbetriq |
| Sanofi Pasteur INC. | $29.18 | 2023 | |
| Genzyme Corporation | $26.28 | 2022 | |
| Exeltis, USA INC. | $23.52 | 2024 | Slynd |
| Radius Health, INC. | $20.85 | 2024 | Tymlos |
| Otsuka America Pharmaceutical, INC. | $20.17 | 2023 | Rexulti |
| Biohaven Pharmaceuticals, INC. | $16.63 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $15.29 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $15.17 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $13.70 | 2022 | |
| Alkermes, INC. | $13.51 | 2023 | Vivitrol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miranda Tsoumas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.